The United States warns of counterfeit drugs for diabetes Ozempic
Kyiv • UNN
The U.S. Food and Drug Administration (FDA) has warned of counterfeit diabetes drugs in the U.S. supply chain, advising to check specific batches and serial numbers.
The US Food and Drug Administration has warned consumers of counterfeit Food and Drug Administration has warned consumers about counterfeit Ozempic diabetes drugs that have been found in the drug supply chain. This was reported by Reuters, according to UNN.
Details
The agency said it would continue to investigate counterfeit Ozempic injections and seized thousands of units, adding that some of the fakes may still be on the market. may still be on the market.
Danish drugmaker Novo Nordisk and the FDA are testing the seized products and do not yet have information on the identity, quality or safety of the drugs, the agency said.
The drug manufacturer reported that the confiscations took place in warehouses outside the company's authorized supply chain.
The agency stated that the needles from the seized injections were fake and their sterility could not be confirmed, which creates an additional risk of of infecting patients.
Other confirmed counterfeit components of the of the seized products include the pen label and accompanying information about the and patient information, as well as the cardboard packaging.
The FDA has urged drug distributors, retail pharmacies, health care providers and patients to check the medicines they have received and not to distribute or use medicines marked with the batch number NAR0074 and serial number 430834149057.
AddendumAddendum
Demand for Ozempic exceeds supply in the United States, Germany, and Britain, as Ozempic leads to dramatic weight loss, so often people use it not for its for weight loss, i.e. not for its authorized use.
